Xtant Medical Holdings (XTNT) Income from Continuing Operations (2010 - 2025)

Xtant Medical Holdings' (XTNT) quarterly Income from Continuing Operations came in at 57000.0 in Q4 2025, up 101.8% year-on-year from 28245.66 in Q4 2024, and down 95.64% on a QoQ basis from 1308000.0 in Q3 2025.

Xtant Medical Holdings (XTNT) Income from Continuing Operations (2010 - 2025) Analysis & Trends

Xtant Medical Holdings (XTNT) has 16 years of Income from Continuing Operations data on file, last reported at 57000.0 in Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 101.8% year-over-year to 57000.0 in Q4 2025; TTM through Dec 2025 was 4973000.0, a 130.23% increase from a year earlier, with the FY2025 full-year figure at 4973000.0, up 130.23% from the prior year.
  • Income from Continuing Operations for Q4 2025 stood at 57000.0, down from 1308000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for XTNT reached as high as 9231000.0 in Q3 2023 and fell as low as 6204000.0 in Q4 2023.
  • Historically, Income from Continuing Operations has averaged 1251700.0 across 5 years, with a median of 1941000.0 in 2021.
  • Across the five-year window, Income from Continuing Operations sank 7531.03% in 2022 and jumped 492.31% in 2023, its largest moves.
  • Year by year, Income from Continuing Operations stood at 1265000.0 in 2021, then sank by 74.62% to 2209000.0 in 2022, then tumbled by 180.85% to 6204000.0 in 2023, then surged by 48.98% to 3165000.0 in 2024, then jumped by 101.8% to 57000.0 in 2025.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were 57000.0 in Q4 2025, 1308000.0 in Q3 2025, and 3550000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.08 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 745.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 380.70 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 199.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 273.95 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 411.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Xtant Medical Holdings 5.69 Mn -11.63 Mn 17.75 Mn 57,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 57,000.00
Sep 30, 2025 1.31 Mn
Jun 30, 2025 3.55 Mn
Mar 31, 2025 58,000.00
Dec 31, 2024 -3.17 Mn
Sep 30, 2024 -5.02 Mn
Jun 30, 2024 -3.86 Mn
Mar 31, 2024 -4.40 Mn
Dec 31, 2023 -6.20 Mn
Sep 30, 2023 9.23 Mn
Jun 30, 2023 -2.19 Mn
Mar 31, 2023 -2.08 Mn
Dec 31, 2022 -2.21 Mn
Sep 30, 2022 -2.35 Mn
Jun 30, 2022 -1.71 Mn
Mar 31, 2022 -2.21 Mn
Dec 31, 2021 -1.27 Mn
Sep 30, 2021 -1.80 Mn
Jun 30, 2021 -733,000.00
Mar 31, 2021 -29,000.00